Prime Medicine, Inc. (PRME) Stock Statistics & Valuation Metrics

Prime Medicine, Inc. has a market cap or net worth of $856.10M. The enterprise value is $671.37M.

Prime Medicine, Inc. has 181,376,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Prime Medicine, Inc.’s return on equity (ROE) is -1.66 and return on invested capital (ROIC) is -66.48%.

The current PE Ratio of Prime Medicine, Inc. is ―. Prime Medicine, Inc.’s PEG ratio is 0.14.

In the last 12 months, Prime Medicine, Inc. had revenue of 4.63M and earned -201.14M in profits. Earnings per share was -1.35.

In the last 12 months, operating cash flow was -156.05M and capital expenditures -797.00K, giving a free cash flow of -156.85M billion.

Prime Medicine, Inc. pays an annual dividend of $0.006, resulting in a dividend yield of 6.8%

Prime Medicine, Inc. upcoming earnings date is Mar 10, 2027, Before Open (Confirmed).

Prime Medicine, Inc. as a current ratio of 4.84, with Debt / Equity ratio of 282.54%

In the past 12 months, Prime Medicine, Inc. has paid 0.00 in taxes.

Prime Medicine, Inc. EV to EBITDA ratio is -2.91, with an EV/FCF ratio of -3.41.

Prime Medicine, Inc. has $95.07M in cash and marketable securities with $112.48M in debt, giving a net cash position of -$17.41M billion.

Gross margin is -1025.61%, with operating margin of -4498.06%, and net profit margin of -4342.44%.

The average price target for Prime Medicine, Inc. is $7.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy